Haleon (NYSE:HLN – Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.05 EPS for the quarter, Zacks reports. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The business had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.38 billion.
Haleon Price Performance
Shares of NYSE:HLN traded up $0.30 during mid-day trading on Friday, reaching $10.09. The stock had a trading volume of 2,704,722 shares, compared to its average volume of 10,134,119. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a market cap of $45.66 billion, a P/E ratio of 29.63, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28. Haleon has a 1 year low of $7.89 and a 1 year high of $10.80. The business’s 50 day moving average price is $9.59 and its 200 day moving average price is $9.83.
Analyst Ratings Changes
Several brokerages have recently commented on HLN. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Haleon has a consensus rating of “Moderate Buy” and an average target price of $10.95.
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Read More
- Five stocks we like better than Haleon
- Should You Invest in Penny Stocks?
- 5 Best Gold ETFs for March to Curb Recession Fears
- Basic Materials Stocks Investing
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- Ride Out The Recession With These Dividend Kings
- Why Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
